Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 02, 2015 08:30 ET | Source: Aldeyra Therapeutics

Aldeyra Therapeutics Provides Update on NS2 Clinical Program

LEXINGTON, Mass., March 2, 2015 (GLOBE NEWSWIRE) -- Aldeyra Therapeutics, Inc. (Nasdaq:ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to free...
February 23, 2015 08:30 ET | Source: Aldeyra Therapeutics

Aldeyra Therapeutics to Present at Cowen and Company 35th Annual Health Care Conference

LEXINGTON, Mass., Feb. 23, 2015 (GLOBE NEWSWIRE) -- Aldeyra Therapeutics, Inc. (Nasdaq:ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to free...
February 02, 2015 08:30 ET | Source: Aldeyra Therapeutics

Aldeyra Therapeutics Abstracts Accepted for Presentation at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology

LEXINGTON, Mass., Feb. 2, 2015 (GLOBE NEWSWIRE) -- Aldeyra Therapeutics, Inc. (Nasdaq:ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to free...
January 29, 2015 08:30 ET | Source: Aldeyra Therapeutics

Aldeyra Therapeutics to Present Novel Data on a Potential Treatment for Sjogren-Larsson Syndrome at the 2015 Society for Inherited Metabolic Disorders Annual Meeting

LEXINGTON, Mass., Jan. 29, 2015 (GLOBE NEWSWIRE) -- Aldeyra Therapeutics, Inc. (Nasdaq:ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to free...
January 26, 2015 08:30 ET | Source: Aldeyra Therapeutics

Aldeyra Therapeutics to Participate in Canaccord Genuity Rare Disease, BioPharma One-on-One Day

LEXINGTON, Mass., Jan. 26, 2015 (GLOBE NEWSWIRE) -- Aldeyra Therapeutics, Inc. (Nasdaq:ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to free...
January 22, 2015 08:30 ET | Source: Aldeyra Therapeutics

Aldeyra Therapeutics Completes $2.0 Million Private Placement

LEXINGTON, Mass., Jan. 22, 2015 (GLOBE NEWSWIRE) -- Aldeyra Therapeutics, Inc. (Nasdaq:ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to free...
January 20, 2015 08:30 ET | Source: Aldeyra Therapeutics

Aldeyra Therapeutics Announces $2.0 Million Private Placement

LEXINGTON, Mass., Jan. 20, 2015 (GLOBE NEWSWIRE) -- Aldeyra Therapeutics, Inc. (Nasdaq:ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to free...
January 15, 2015 08:30 ET | Source: Aldeyra Therapeutics

Aldeyra Therapeutics Completes $7.79 Million Private Placement

LEXINGTON, Mass., Jan. 15, 2015 (GLOBE NEWSWIRE) -- Aldeyra Therapeutics, Inc. (Nasdaq:ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to free...
January 13, 2015 08:30 ET | Source: Aldeyra Therapeutics

Aldeyra Therapeutics Announces $7.79 Million Private Placement

LEXINGTON, Mass., Jan. 13, 2015 (GLOBE NEWSWIRE) -- Aldeyra Therapeutics, Inc. (Nasdaq:ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to free...
January 05, 2015 08:30 ET | Source: Aldeyra Therapeutics

Aldeyra Therapeutics Submits IND Filing to FDA for Clinical Testing of NS2 in Patients With Sjogren-Larsson Syndrome

LEXINGTON, Mass., Jan. 5, 2015 (GLOBE NEWSWIRE) -- Aldeyra Therapeutics, Inc. (Nasdaq:ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to free...